PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
20-Aug-2020 Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use AstraZeneca
20-Aug-2020 Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology Amarin Corporation plc
20-Aug-2020 Kiadis collaborates with premier Dutch institutions to apply K-NK-cell technology for the development of a novel COVID-19 therapy Kiadis Pharma N.V.
14-Aug-2020 Akshaya Patra foundation and Cadila Pharma help 3000 students at their homes through mid-day meals Cadila Pharmaceuticals Ltd
14-Aug-2020 UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc. UNION therapeutics A/S
14-Aug-2020 Sosei Heptares Operational Highlights and Consolidated Results for the First Half 2020 Sosei Heptares
14-Aug-2020 Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study Bone Therapeutics
14-Aug-2020 Daridorexant Phase 3 results in insomnia to be presented at SLEEP 2020 Idorsia Ltd
13-Aug-2020 SMi’s Pharmaceutical Microbiology East Coast Conference - A Virtual Conference with Remote Access Only SMi Group
13-Aug-2020 HOLOGRAPHIC LABELS SUCCESSFULLY PRESCRIBED IN BATTLE TO FOIL COUNTERFEITERS Eltronis
12-Aug-2020 Ligandal develops effective antidote to SARS-CoV-2 Liganda
12-Aug-2020 Cough and cold-killing extract to be grown hydroponically creating reliable, year-round source for first time Vertical Future
12-Aug-2020 PTC Therapeutics Announces FDA Approval of Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older PTC Therapeutics, Inc
12-Aug-2020 FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting FibroGenesis
12-Aug-2020 Advent Life Sciences announces sale of its portfolio Company KaNDy Therapeutics to Bayer AG for USD 425M upfront plus USD 450M in potential development milestones followed by further potential commercial milestones Advent Life Sciences
12-Aug-2020 Newron Pharmaceuticals provides clinical and business update Newron Pharmaceuticals
12-Aug-2020 Pre-Close Trading Statement Sareum Holdings PLC
12-Aug-2020 Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication Saillant Therapeutics
12-Aug-2020 Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates Abeona Therapeutics
12-Aug-2020 CPhI South East Asia rescheduled for 2021 CPhI SEA